Solomiya Paryzhak

Solomiya Paryzhak

Auto-generated profile, based on publicly available information

Solomiya Paryzhak

Department of Medical Biology, Parasitology and Genetics, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
VRViktor Reshetnikov
Viktor Reshetnikov
SDSteffen Daum
Steffen Daum
CJChristina Janko
Christina Janko
WKWeronika Karawacka
Weronika Karawacka
RTRainer Tietze
Rainer Tietze
AMAndriy Mokhir
Andriy Mokhir

10 October 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
CLChengnan Li
Chengnan Li
RYRan Ye
Ran Ye
JBJulie Bouckaert
Julie Bouckaert
AZAmaia Zurutuza
Amaia Zurutuza
DDDjamel Drider
Djamel Drider
SSSabine Szunerits
Sabine Szunerits

15 August 2008 in Talanta
Verified
Journal Article
Closed access
ODOlha Demkiv
Olha Demkiv
OSOleh Smutok
Oleh Smutok
SPSolomiya Paryzhak
Solomiya Paryzhak
GGGalina Gayda
Galina Gayda
YSYusif Sultanov
Yusif Sultanov
MGMykhailo Gonchar
Mykhailo Gonchar

1 January 2019 in Materials Today
Verified
Journal Article
Closed access
Rostyslav BilyyRostyslav Bilyy
Rostyslav Bilyy
SPSolomiya Paryzhak
Solomiya Paryzhak
KTKostiantyn Turcheniuk
Kostiantyn Turcheniuk
TDTetiana Dumych
Tetiana Dumych
ABAlexandre Barras
Alexandre Barras
SSSabine Szunerits
Sabine Szunerits

1 June 2007 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
BMBen Ali Mounir
Ben Ali Mounir
MGMykhailo Gonchar
Mykhailo Gonchar
GGGalina Gayda
Galina Gayda
SPS. Paryzhak
S. Paryzhak
MMM.A. Maaref
M.A. Maaref
YKYaroslav Korpan
Yaroslav Korpan

18 August 2018 in Autoimmunity
Verified
Journal Article
Closed access
SPS. Paryzhak
S. Paryzhak
TDT. Dumych
T. Dumych
IMI. Mahorivska
I. Mahorivska
MBM. Boichuk
M. Boichuk
GBGalyna Bila
Galyna Bila
Rostyslav BilyyRostyslav Bilyy
Rostyslav Bilyy
During NET formation, the content of neutrophils granules is released into the intercellular milieu. Consisting of many proteases and ROS species, formed NETs were shown to degrade cytokines (Schauer, Nat Med, 2014); while the content of neutrophil’s azurophilic granules proved to contain glycosidases, secreted upon activation (Thaysen-Andersen, JBC, 2015), and formation of autoantibodies to neutrophil beta-glucoronidase was connected with the level of anti-MPO antibodies (Ab) (Martensson, Autoimmunity, 1992). Taking into account these facts, we aimed to investigate the possibility of NET-related changes in glycan composition on circulating IgG molecules and IgG–IgM immune complexes in multiple sclerosis (MS). This autoimmune disorder still has no reliable detection markers or established ways of treatment, besides widely accepted interferon therapy, making it a particularly interesting clinical condition. By applying capture lectin-ELISA, we analysed binding of α2,6 sialyl-specific lectins SNA, PSqL, and core α1,6-fucose specific lectin AAL to circulating IgG and related complexes in five groups of MS patients: untreated (17 persons); undergoing therapy with interferon (IFN) β-1 b (15 persons), corticosteroids (methylprednisolone) (12 persons) and anti-B-cell monoclonal Ab (12 persons: Ocrelizumab, 6 persons and alemtuzumab, 6 persons). A group of 23 healthy donors served as control. Significant increase in neutrophil elastase activity, observed in the group of patients under corticosteroid treatment was also accompanied by sialyl-specific PSqL and SNA lectin binding to captured IgG molecules. Subsequent analysis demonstrated that sialic acid residues were exposed on free IgG and on circulating IgG–IgM immune complexes. Increased lectin binding was not observed for anti-myelin basic protein (one of the major autoAb in MS) Ab compared to total serum Ab. IFN therapy was accompanied by low neutrophil elastase activity and low amount of circulating immune complexes. Incubation of in vitro generated NETs with human serum revealed the digestion of high-molecular weight immune complexes with subsequent exposure of hidden glycoepitops. Obtained data indicate the potential of neutrophil-derived proteases to modify (partially degrade) circulating immune complexes leading to exposure of internal glycoepitops.